HIV AIDS classification: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(28 intermediate revisions by 7 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{AIDS}}
{{AIDS}}
{{CMG}} ; {{AE}} {{Ammu}}
{{CMG}}; {{AE}} {{Ammu}}


==Overview==
==Overview==
Since June 5, 1981, many definitions have been developed for [[epidemiology|epidemiological]] surveillance such as the Bangui definition and the 1994 expanded World Health Organization AIDS case definition. However, clinical staging of patients was not an intended use for these systems as they are neither sensitive, nor specific. In developing countries, the [[World Health Organization]] staging system for HIV infection and disease, using clinical and laboratory data, is used and in developed countries, the [[Centers for Disease Control and Prevention|Centers for Disease Control]] (CDC) Classification System is used.
Many definitions have been developed for [[epidemiology|epidemiological]] surveillance of HIV/AIDS such as the ''Bangui definition'' and the ''1994 Expanded World Health Organization AIDS Case Definition''. However, these systems are neither sensitive nor specific for clinical staging. In developing countries, the [[World Health Organization]] staging system for HIV infection and disease that uses clinical and laboratory data is widely employed. The [[Centers for Disease Control and Prevention|Centers for Disease Control]] (CDC) Classification System for HIV/AIDS is another primary system used that is primarily based on [[T helper cells|CD4 T-lymphocyte]] counts.
 
==Classification==
==Classification==
=== WHO Disease Staging System for HIV Infection and Disease ===
===WHO Staging System for HIV Infection and Disease in Adults and Adolescents<ref name=who>WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. 2006.</ref>===
In 1990, the [[World Health Organization]] (WHO) grouped these infections and conditions together by introducing a staging system for patients infected with HIV-1.<ref name=WHO>{{
 
cite journal
| author=World Health Organization
| title=Interim proposal for a WHO staging system for HIV infection and disease
| journal=WHO Wkly Epidem. Rec. | year=1990 | pages=221&ndash;228 | volume=65 | issue=29
| pmid=1974812
 
}}</ref> An update took place in September 2005. Most of these conditions are [[opportunistic infection]]s that are easily treatable in healthy people.
* Stage I: HIV infection is [[asymptomatic]] and not categorized as AIDS
* Stage II: includes minor [[Mucous membrane|mucocutaneous]] manifestations and recurrent [[upper respiratory tract]] infections
* Stage III: includes unexplained [[Chronic (medical)|chronic]] [[diarrhea]]<!--STOP CHANGING THIS: this article is written in American English throughout. --> for longer than a month, severe bacterial infections and [[pulmonary]] tuberculosis
* Stage IV: includes [[toxoplasmosis]] of the [[brain]], [[candidiasis]] of the [[esophagus]], [[Vertebrate trachea|trachea]], [[bronchi]] or [[lung]]s and [[Kaposi's sarcoma]]; these diseases are indicators of AIDS.
 
===WHO Staging System for HIV Infection and Disease in Adults and Adolescents<small><ref name=CDC>{{cite web | title = CDC Global AIDS module| url = http://www.cdc.gov/globalaids/Resources/pmtct-care/docs/PM/Module_1PM.pdf }}</ref></small>===


{| style="border: 0px; font-size: 90%; margin: 3px; width:950px " align=center
{| style="border: 0px; font-size: 90%; margin: 3px; width:950px " align=center
Line 41: Line 27:
*Papular pruritic eruptions
*Papular pruritic eruptions
*Angular cheilitis
*Angular cheilitis
*[[Seborrhoeic]] [[dermatitis]]
*Seborrhoeic [[dermatitis]]
*Fungal [[finger nail]] [[infections]]
*Fungal [[finger nail]] [[infections]]
|-
|-
Line 90: Line 76:
|}
|}


===WHO Staging System for HIV Infection and Disease in Children===
===WHO Staging System for HIV Infection and Disease in Children (Revised 2006) <ref name=who>WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. 2006.</ref>===
 
{| style="border: 0px; font-size: 90%; margin: 3px; width:950px;" align=center
{| style="border: 0px; font-size: 90%; margin: 3px; width:950px;" align=center
! style="background: #4479BA; width: 120px;" | {{fontcolor|#FFF|Clinical stage}}
! style="background: #4479BA; width: 120px;" | {{fontcolor|#FFF|Clinical stage}}
Line 104: Line 89:
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" |
*[[Hepatosplenomegaly]]
*[[Hepatosplenomegaly]]
*[[Papular pruritic eruptions]]
*Papular pruritic eruptions
*[[Seborrhoeic dermatitis]]
*[[Seborrhoeic dermatitis]]
*Extensive [[human papilloma virus infection]]
*Extensive human papilloma virus infection
*Extensive [[molluscum contagiosum]]
*Extensive [[molluscum contagiosum]]
*Fungal [[nail]] [[infections]]
*Fungal nail [[infections]]
*Recurrent [[oral ulcerations]]
*Recurrent [[oral ulcerations]]
*[[Linear gingival erythema]] (LGE)
*Linear gingival erythema (LGE)
*Angular [[cheilitis]]
*Angular [[cheilitis]]
*[[Parotid]] enlargement
*[[Parotid]] enlargement
Line 144: Line 129:
*Unexplained severe wasting or severe [[malnutrition]] not adequately responding to standard therapy
*Unexplained severe wasting or severe [[malnutrition]] not adequately responding to standard therapy
*[[Pneumocystis pneumonia]]
*[[Pneumocystis pneumonia]]
*Recurrent severe presumed bacterial [[infections]] (e.g. [[empyema]], [[pyomyositis]], [[bone]] or [[joint infection]], [[meningitis]], but excluding [[pneumonia]])
*Recurrent severe presumed bacterial [[infections]] (e.g. [[empyema]], [[pyomyositis]], [[bone]] or joint infection, [[meningitis]], but excluding [[pneumonia]])
*Chronic [[herpes simplex]] infection; (orolabial or cutaneous of more than one month’s duration)
*Chronic [[herpes simplex]] infection; (orolabial or cutaneous of more than one month’s duration)
*Extrapulmonary [[Tuberculosis]]
*Extrapulmonary [[Tuberculosis]]
*[[Kaposi’s sarcoma]]
*Kaposi’s sarcoma
*Oesophageal [[candidiasis]]
*Oesophageal [[candidiasis]]
*Central nervous system [[toxoplasmosis]] (outside the neonatal period)
*Central nervous system [[toxoplasmosis]] (outside the neonatal period)
Line 157: Line 142:
*[[Cryptosporidiosis]]
*[[Cryptosporidiosis]]
*[[Isosporiasis]]
*[[Isosporiasis]]
*Disseminated non-tuberculous [[mycobacteria infection]]
*Disseminated non-tuberculous mycobacteria infection
*[[Candida]] of trachea, bronchi or lungs
*[[Candida]] of trachea, bronchi or lungs
*Visceral [[herpes simplex infection]]
*Visceral herpes simplex infection
*Acquired [[HIV]] associated rectal fistula
*Acquired [[HIV]] associated rectal fistula
*Cerebral or B cell [[non-Hodgkin lymphoma]]
*Cerebral or B cell [[non-Hodgkin lymphoma]]
Line 166: Line 151:
|}
|}


===CDC Classification System for HIV Infection===
==CDC Classification System==


*In the beginning, the [[Centers for Disease Control and Prevention]] (CDC) did not have an official name for the disease, often referring to it by way of the diseases that were associated with it, for example, [[lymphadenopathy]], the disease after which the discoverers of HIV originally named the virus.<ref name=MMWR1982a>{{
The table below shows the HIV infection stage, based on age-specific CD4+ T-lymphocyte count or CD4+ T-lymphocyte percentage of total lymphocytes. <ref> {{cite web| url=http://www.cdc.gov/hiv/statistics/recommendations/terms.html| title=CDC HIV/AIDS Surveillance Publications}}</ref>


cite journal
{{#widget:BlueTable}}
| author=Centers for Disease Control (CDC)
{|class="BlueTable" style="width: 500px"
| title=Persistent, generalized lymphadenopathy among homosexual males.
!rowspan=3|Stage*
| journal=MMWR Morb Mortal Wkly Rep. | year=1982 | pages=249&ndash;251 | volume=31| issue=19
!colspan=6|Age on date of CD4 T-lymphocyte test
| pmid=6808340
|-
 
! colspan=2|<1 year
}}</ref><ref name=Barre>{{cite journal | author=Barré-Sinoussi F, Chermann JC, Rey F, et al | title=Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) | journal=Science | year=1983 | pages=868–871 | volume=220 | issue=4599 | pmid=6189183 | doi=10.1126/science.6189183 | format=
! colspan=2|1—5 years
}}</ref>
! colspan=2|6 years through adult
*They also used ''Kaposi's Sarcoma and Opportunistic Infections'', the name by which a task force had been set up in 1981.<ref name=MMWR1982b>{{
|-
 
! Cells/µL||%||Cells/µL||%||Cells/µL||%
cite journal
|-
| author=Centers for Disease Control (CDC)
| 1||≥1,500||≥34||≥1,000||≥30||≥500||≥26
| title=Opportunistic infections and Kaposi's sarcoma among Haitians in the United States
|-
| journal=MMWR Morb Mortal Wkly Rep. | year=1982 | pages=353&ndash;354; 360&ndash;361 | volume=31 | issue=26
| 2||750—1,499||26—33||500—999||22—29||200—499||14—25
| pmid=6811853
|-
 
| 3||<750||<26||<500||<22||<200||<14
}}</ref>
|-
*In the general press, the term ''GRID'', which stood for [[Gay-related immune deficiency]], had been coined.<ref name=Altman>{{
|colspan=7|<small> *The stage is based primarily on the CD4+ T-lymphocyte count; the CD4+ T-lymphocyte count takes precedence over the CD4 T-lymphocyte percentage, and the percentage is considered only if the count is missing.</small>
 
|}
cite news
| author=Altman LK
| title=New homosexual disorder worries officials
| work=The New York Times | date=1982-05-11
 
}}</ref>
*However, after determining that AIDS was not isolated to the homosexual community,<ref name=MMWR1982b/> the term GRID became misleading and ''AIDS'' was introduced at a meeting in July 1982.<ref name=Kher>{{
 
cite news
| author=Kher U
| title=A Name for the Plague
| work=Time | date=1982-07-27 | url=http://www.time.com/time/80days/820727.html |accessdate=2008-03-10
 
}}</ref>
*By September 1982 the CDC started using the name AIDS, and properly defined the illness.<ref name=MMWR1982c>{{
 
cite journal
| author=Centers for Disease Control (CDC)
| title=Update on acquired immune deficiency syndrome (AIDS)—United States.
| journal=MMWR Morb Mortal Wkly Rep. | year=1982 | pages=507&ndash;508; 513&ndash;514 | volume=31 | issue=37
| pmid=6815471
 
}}</ref>
*In 1993, the CDC expanded their definition of AIDS to include all HIV positive people with a CD4<SUP>+</SUP> T cell count below 200 per µL of blood or 14% of all [[lymphocyte]]s.<ref name=MMWR>{{
 
cite web | publisher=[[Centers for Disease Control and Prevention|CDC]] | publisher=CDC | year=1992
| url=http://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm
| title=1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults
| accessdate = 2006-02-09
 
}}</ref>  
*The majority of new AIDS cases in developed countries use either this definition or the pre-1993 CDC definition. The AIDS diagnosis still stands even if, after treatment, the CD4<SUP>+</SUP> T cell count rises to above 200 per µL of blood or other AIDS-defining illnesses are cured.
 
{{further|[[CDC Classification System for HIV Infection in Adults and Adolescents]]}}
 
{{further|[[CDC Classification System for HIV Infection in Children]]}}


==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WH}}
{{WS}}


[[Category:HIV/AIDS]]
[[Category:HIV/AIDS]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Immune system disorders]]
[[Category:Immune system disorders]]
[[Category:Infectious disease]]
[[Category:Viral diseases]]
[[category:viral diseases]]
[[Category:Pandemics]]
[[Category:Pandemics]]
[[Category:Sexually transmitted infections]]
[[Category:Sexually transmitted infections]]
Line 243: Line 194:
[[Category:Immunodeficiency]]
[[Category:Immunodeficiency]]
[[Category:Microbiology]]
[[Category:Microbiology]]
{{WH}}
[[Category:Emergency mdicine]]
{{WS}}
[[Category:Up-To-Date]]
[[Category:Infectious disease]]

Latest revision as of 22:11, 29 July 2020

Sexually transmitted diseases Main Page

AIDS Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating AIDS from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

HIV Opportunistic Infections

HIV Coinfections

HIV and Pregnancy

HIV Infection in Infants

Diagnosis

Diagnostic Study of Choice

AIDS Case Definition

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Nutrition
Drug Resistance

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

HIV Vaccine

Case Studies

Case #1

HIV AIDS classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of HIV AIDS classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on HIV AIDS classification

CDC on HIV AIDS classification

HIV AIDS classification in the news

Blogs on HIV AIDS classification

Directions to Hospitals Treating AIDS

Risk calculators and risk factors for HIV AIDS classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Many definitions have been developed for epidemiological surveillance of HIV/AIDS such as the Bangui definition and the 1994 Expanded World Health Organization AIDS Case Definition. However, these systems are neither sensitive nor specific for clinical staging. In developing countries, the World Health Organization staging system for HIV infection and disease that uses clinical and laboratory data is widely employed. The Centers for Disease Control (CDC) Classification System for HIV/AIDS is another primary system used that is primarily based on CD4 T-lymphocyte counts.

Classification

WHO Staging System for HIV Infection and Disease in Adults and Adolescents[1]

Clinical stage Features
Clinical stage 1
Clinical stage 2
Clinical stage 3

Conditions where a presumptive diagnosis can be made on the basis of clinical signs or simple investigations

Conditions where confirmatory diagnostic testing is necessary

Clinical stage 4

Conditions where a presumptive diagnosis can be made on the basis of clinical signs or simple investigations

Conditions where confirmatory diagnostic testing is necessary

WHO Staging System for HIV Infection and Disease in Children (Revised 2006) [1]

Clinical stage Features
Clinical stage 1
Clinical stage 2
Clinical stage 3

Conditions where a presumptive diagnosis can be made on the basis of clinical signs or simple investigations

Conditions where confirmatory diagnostic testing is necessary

Clinical stage 4

Conditions where a presumptive diagnosis can be made on the basis of clinical signs or simple investigations

Conditions where confirmatory diagnostic testing is necessary

CDC Classification System

The table below shows the HIV infection stage, based on age-specific CD4+ T-lymphocyte count or CD4+ T-lymphocyte percentage of total lymphocytes. [2]

Stage* Age on date of CD4 T-lymphocyte test
<1 year 1—5 years 6 years through adult
Cells/µL % Cells/µL % Cells/µL %
1 ≥1,500 ≥34 ≥1,000 ≥30 ≥500 ≥26
2 750—1,499 26—33 500—999 22—29 200—499 14—25
3 <750 <26 <500 <22 <200 <14
*The stage is based primarily on the CD4+ T-lymphocyte count; the CD4+ T-lymphocyte count takes precedence over the CD4 T-lymphocyte percentage, and the percentage is considered only if the count is missing.

References

  1. 1.0 1.1 WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. 2006.
  2. "CDC HIV/AIDS Surveillance Publications".

Template:WH Template:WS